Goldport Capital

Goldport Capital is an asset management company based in Shenzhen, China, with an additional office in Hangzhou. Founded in 2012, the firm specializes in venture capital investments across various sectors, including advanced manufacturing, new energy, healthcare, and consumption upgrades. Goldport Capital aims to identify and support innovative companies within these industries to drive growth and technological advancement.

Houbo Cheng

Founding Partner

Zhen Li

Partner

53 past transactions

Zinc Core Titanium

Series A in 2025
Zinc Core Titanium makes special materials that light up and tiny screens for displays.

Yisite Biotech

Series A in 2025
Yisite Biotech is a technology-driven enterprise that concentrates on advancements in the field of synthetic biology.

Chaoguang Micro

Seed Round in 2025
Chaoguang Micro specializes in the innovative development of optical products for medical and industrial purposes.

Teyan Semiconductor

Series B in 2025
Teyan Semiconductor is a provider of semiconductor process and equipment services, specializing in advanced packaging solutions. The company offers a range of production lines, including System in Package (SiP), Fanout, Chiplet, and 3D packaging. Teyan Semiconductor also manufactures precision industrial laser equipment, which includes laser marking, welding, drilling, and cutting machines. These products enable high-end manufacturing in the semiconductor industry, catering to the growing demands for sophisticated packaging technologies and precision manufacturing processes.

Omnivision

Seed Round in 2024
Omnivision operates as a semiconductor design company. It is committed to providing sensor solutions, analog solutions, and touch screen and displays solutions to help customers in mobile phone, security, automotive electronics, wearable devices, IoT, communications, computers, consumer electronics, industrial, medical, and other fields of technical challenges to meet the ever-increasing demand for artificial intelligence and green energy.

Depp CNC

Series A in 2024
Depu CNC is a developer and manufacturer of high-end computer numerical control (CNC) tools designed for industrial and mechanical applications. The company specializes in producing machine tools and core accessories, including four- and five-axis CNC turntables, rotary tables, swing heads, and optical probes. Their products serve various sectors, such as civil aviation, automotive parts, ship equipment, and 3C accessories. By providing high-quality machine tool solutions, Depu CNC addresses customer inquiries through multiple channels, including phone, email, and online applications, ensuring effective communication and support.

Fast Photonics

Series B in 2024
Fast Photonics is engaged in the development and manufacturing of high-speed optical transceivers, catering to the growing demands of optical communication technology. The company specializes in products tailored for applications such as 5G access, FTTX, and data center interconnects. With a strong emphasis on innovation, Fast Photonics focuses on creating solutions that facilitate efficient data transmission across communication networks. The company also provides customized offerings as an OEM, ODM, and JDM partner, addressing specific customer needs. Its commitment to quality is underscored by ISO certification, ensuring adherence to high manufacturing standards. Through its expertise in optical technology, Fast Photonics positions itself as a significant player in the industry, dedicated to enhancing the efficiency and speed of data communication.

Ruigu New Materials

Seed Round in 2024
Ruigu New Materials is a new energy battery technology developer that specializes in the research, development, and manufacture of new energy battery technology, as well as the research, development, and production of sulfide solid electrolytes.

REEM Healthcare

Series A in 2024
REEM Healthcare is a new type of medical device R&D and manufacturing company focused on the development and production of PHIS tiny particle units (professional, wearable, and implantable), new medical device IoT goods, and the provision of professional smart disease management services.Ruimeng Medical brings together senior experts in medical devices, health management, mobile Internet, big data processing, and other fields to form a new medical device R&D and production enterprise dedicated to the R&D and production of PHIS small particle units (professional, wearable, and implantable), new medical device IoT products, and professional intelligent disease management services.

Xingrong Technology

Seed Round in 2024
Xingrong Technology is an electronic component company that offers services to consumers including fabrication of electronic components.

Depp CNC

Seed Round in 2024
Depu CNC is a developer and manufacturer of high-end computer numerical control (CNC) tools designed for industrial and mechanical applications. The company specializes in producing machine tools and core accessories, including four- and five-axis CNC turntables, rotary tables, swing heads, and optical probes. Their products serve various sectors, such as civil aviation, automotive parts, ship equipment, and 3C accessories. By providing high-quality machine tool solutions, Depu CNC addresses customer inquiries through multiple channels, including phone, email, and online applications, ensuring effective communication and support.

Didao Microelectronics

Venture Round in 2024
Shenzhen Didao Microelectronics Technology is a company specializing in the research, production, and sales of electronic special materials, primarily for the semiconductor and flat panel display industries. The firm develops and manufactures products such as semiconductor cleaning agents and various types of photoresists, which are essential for lithography processes in integrated circuits and flat panel displays. With backing from venture capital, Didao Microelectronics aims to advance the technology and application of its specialized materials, contributing to the growth and innovation in the electronic manufacturing sector.

Hongxin Biology

Seed Round in 2024
Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.

Hengruiyuan

Series C in 2024
Hengruiyuan is a biopharmaceutical company that develops medications based on immune cell treatment technologies for solid tumors.

Xingchenhai

Series A in 2024
Xingchenhai is a technology company that focuses on technology research and development of drone scenario applications for the field of low-altitude security, and major scientific research projects in military and government-related fields.

RegenGeek

Series A in 2023
RegenGeek is a company specializing in regenerative medicine, focusing on the research and development of advanced stem cell technology. It offers large-scale stem cell production solutions, including cell development equipment and consumables such as serum-free media, microcarriers, and bioreactors. Additionally, RegenGeek provides modular Good Manufacturing Practice (GMP) working warehouses and technical support services, facilitating a comprehensive solution for hospitals and stem cell pharmaceutical companies. The company's innovative approach aims to streamline the production and application of regenerative medicine, enhancing the capabilities of its clients in the healthcare sector.

HOKO

Venture Round in 2023
HOKO is a manufacturer that combines the design, manufacture, marketing, and after-sales care of air purifiers.

Gubang Semiconductor

Series A in 2023
Gubang Semiconductor is a technology company that specializes in the development and provision of semiconductor devices, wearable intelligent devices, and intelligent data management platforms. The company's core business revolves around empowering smart city management by integrating terminal devices and information platforms, with a particular focus on power semiconductor devices.

CellOrigin Biotech

Venture Round in 2023
CellOrigin Biotech specializes in the development of innovative therapeutics using induced pluripotent stem cells (iPSCs) to create innate immune cells. The company is dedicated to advancing immune cell technology aimed at treating solid tumors. Its research focuses on the generation of gene-manipulated, clinically applicable iPSCs and the establishment of a clinical iPSC bank. Additionally, CellOrigin Biotech is developing an efficient platform for differentiating iPSCs into mature stem cells, which enhances their potential for therapeutic applications. Through these efforts, the company aims to contribute significantly to the field of cancer treatment.

Xingchenhai

Series A in 2023
Xingchenhai is a technology company that focuses on technology research and development of drone scenario applications for the field of low-altitude security, and major scientific research projects in military and government-related fields.

Powertight

Seed Round in 2023
Powertight is a cutting-edge biopharmaceutical company.

Haisi Biotech

Angel Round in 2023
Haisi Bio specializes in nano-antibody detection and novel biomedicine research and development.

Shenzhen Yurucheng

Series A in 2023
Shenzhen Yurucheng conducts research and development for materials and equipment used in the dental medical industrial chain.

Qianhai Yueshi

Series B in 2023
Qianhai Yueshi is a prominent service provider in China's cold chain industry, focusing on the development of an artificial intelligence-driven cold chain supply chain management platform. The company aims to enhance the efficiency and capabilities of the cold chain sector by leveraging modern technologies such as big data, cloud computing, artificial intelligence, the Internet of Things, and blockchain. Qianhai Yueshi's offerings include cold chain warehousing management, logistics management, transaction management, and information systems tailored for the cold chain, all designed to create an integrated and modernized supply chain ecosystem. Recently, the company secured significant funding to further its technological advancements and service enhancements within the industry.

ESWIN Computing

Series D in 2023
ESWIN Computing specializes in the research and development of RISC-V computing architecture, focusing on the design and testing of integrated circuits for Internet of Things (IoT) applications. The company develops chips used in display devices and wearable technology, providing comprehensive solutions in areas such as artificial intelligence, human-computer interaction, and the Internet of Vehicles. By combining innovative design with advanced materials, ESWIN Computing aims to enhance user experiences across various digital platforms.

Zhongna Times

Angel Round in 2023
Zhongna Times is a company that develops, manufactures, and sells sodium-ion batteries and cathode materials for sodium batteries. It aspires to be the world's leading supplier of battery energy system solutions.The firm develops and applies low-cost, high-rate, high-safety, low-temperature-resistant, and over-discharge-resistant sodium-ion batteries and materials.

Hengruiyuan

Series C in 2023
Hengruiyuan is a biopharmaceutical company that develops medications based on immune cell treatment technologies for solid tumors.

Cuize Medicine

Seed Round in 2023
Cuize Medicine specializes in the research and development of respiratory medicine technology and complex preparation medicine technology. Cuize Medicine emphasizes perioperative and pulmonary therapy medications.

HiStarlink

Series A in 2023
HiStarlink is a commercial company that specializes in the development and manufacturing of advanced communication technology, particularly satellite laser communication systems. The company offers a range of products, including aerospace-grade optoelectronic devices, ultra-high-speed communication boards, laser communication terminals, and ground signal transceiver systems. HiStarlink's innovative solutions are designed to meet the demands of various sectors, including aerospace and national defense, by enhancing communication speed and reducing equipment costs. Through its cutting-edge technology, HiStarlink aims to improve the efficiency and effectiveness of communication systems in the aerospace industry.

SemiShare

Venture Round in 2023
SemiShare is a manufacturer of advanced wafer probe and semiconductor testing equipment. The company specializes in a range of products including manual, semi-automatic, and fully automatic probe stations. Their offerings are designed to meet the testing requirements of various sectors, including universities, research institutes, semiconductor fabrication (FAB) factories, and panel factories. In addition to probe stations, SemiShare provides probe holders, probe fixtures, and laser repair machines for LCD, OLED, and LCVd technologies, supporting both scientific research and mass production needs.

Shenhe Liyang

Seed Round in 2023
Shenhe Liyang develops silicone foam material. Their products include potting glue, ceramic silicone, solid silicone, and silicone foam seals. They provide products, research, and development services for lithium batteries in energy vehicles.

Qianjing Semiconductor

Seed Round in 2023
Qianjing Semiconductor is an enterprise that integrates semiconductor silicon carbide single crystal growth, wafer processing, and equipment development. They offer substrate products for customers in the above fields and also provide semiconductor substrate material solutions for domestic and foreign counterparts, including but not limited to wafer processing services, wafer and crystal testing services, etc.

Linhuiba

Series C in 2023
Linhuiba is a Hangzhou-based platform specializing in the booking of event spaces. It offers a diverse range of venue options, including residential estates, shopping malls, office buildings, subway stations, and other high-traffic locations, making it an ideal resource for merchants seeking to promote products and enhance brand visibility. The company manages over 22,500 venues across first and second-tier cities, facilitating online reservations for pop-up events. By connecting businesses with suitable venues, Linhuiba streamlines the process of venue selection and booking, catering to the needs of various merchants.

Hongxin Biology

Angel Round in 2022
Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.

RegenGeek

Series A in 2022
RegenGeek is a company specializing in regenerative medicine, focusing on the research and development of advanced stem cell technology. It offers large-scale stem cell production solutions, including cell development equipment and consumables such as serum-free media, microcarriers, and bioreactors. Additionally, RegenGeek provides modular Good Manufacturing Practice (GMP) working warehouses and technical support services, facilitating a comprehensive solution for hospitals and stem cell pharmaceutical companies. The company's innovative approach aims to streamline the production and application of regenerative medicine, enhancing the capabilities of its clients in the healthcare sector.

Yurucheng

Series A in 2022
Yurucheng provides dental products. The company also conduct research and development, produce, sell, and service medical and dental materials and equipment.

Lesheng Semiconductor

Seed Round in 2022
Lesheng Semiconductor offers products that include a TFT LCD graphic acceleration display control chip, a TFT serial port display control chip, and a general-purpose 32-bit Flash MCU in automotive, medical, industrial control, instrumentation, small home appliances, and more industries.

Onco Technology

Series A in 2022
Onco Technology is a provider of chip programming equipment and programming solutions.

saisi

Series C in 2022
Saisi focuses on the development, production, and sales of time and frequency system solutions. They are used in many different industries, including high-speed rails, LTE, transportation, hospitals, airports, and more. The company is dedicated to creating personalized time-frequency benchmarks for people from all walks of life.

Crystal Egg Bio

Seed Round in 2022
Crystal Egg is a biopharmaceutical company dedicated to the independent research and development of first in class innovative new drugs for major diseases such as depression, chronic kidney disease, pain and rare diseases, as well as providing customers with high-quality products and R&D services in membrane protein-related fields. enterprise. The company has built membrane protein expression and purification platforms, structural biology platforms, pharmacology platforms and nanobody screening platforms, and has rich R&D pipelines in the fields of ion channels and GPCRs.

Qianhai Yueshi

Series A in 2021
Qianhai Yueshi is a prominent service provider in China's cold chain industry, focusing on the development of an artificial intelligence-driven cold chain supply chain management platform. The company aims to enhance the efficiency and capabilities of the cold chain sector by leveraging modern technologies such as big data, cloud computing, artificial intelligence, the Internet of Things, and blockchain. Qianhai Yueshi's offerings include cold chain warehousing management, logistics management, transaction management, and information systems tailored for the cold chain, all designed to create an integrated and modernized supply chain ecosystem. Recently, the company secured significant funding to further its technological advancements and service enhancements within the industry.

Elevoc

Series B in 2021
Elevoc is an AI-powered audio solution provider focused on enhancing voice communication through advanced technology. The company has developed a deep learning-based voice enhancement solution that operates in real time, allowing it to effectively extract speech from background noise and improve clarity and intelligibility. This innovative technology is utilized across millions of devices globally, catering to various industries including telecommunications, education, automotive, and security. Elevoc's offerings encompass a range of services such as intelligent noise reduction, echo cancellation, reverberation suppression, sound source localization, and beamforming, all aimed at facilitating superior voice signal processing and intelligent voice interaction.

Mould Storage Technology

Series A in 2018
Mould Storage Technology is a general-purpose energy storage system and operation and maintenance management service provider, focusing on the field of new energy storage, providing users with heterogeneous electrical compatibility solutions, and helping users solve the industry's problems with the traditional battery serial topology. The cost problem caused by strong battery consistency.

Pingze

Series A in 2018
Pingze is an original leaf tea and teabag brand in China.

DIAGENS

Series A in 2018
DIAGENS is a Hangzhou-based biotechnology firm, providing in-vitro diagnostic (IVD) products and other medical equipment.

Linhuiba

Series A in 2018
Linhuiba is a Hangzhou-based platform specializing in the booking of event spaces. It offers a diverse range of venue options, including residential estates, shopping malls, office buildings, subway stations, and other high-traffic locations, making it an ideal resource for merchants seeking to promote products and enhance brand visibility. The company manages over 22,500 venues across first and second-tier cities, facilitating online reservations for pop-up events. By connecting businesses with suitable venues, Linhuiba streamlines the process of venue selection and booking, catering to the needs of various merchants.

MicroTech Medical

Series B in 2017
MicroTech Medical, established in January 2011 in Hangzhou Future Technical City, focuses on the research, development, manufacturing, and commercialization of diabetes management devices. The company aims to innovate and produce high-tech and affordable medical devices for diabetes care, including both treatment and monitoring solutions. With a significant portion of its revenue generated in China, MicroTech Medical is dedicated to enhancing diabetes management both domestically and globally. The company has received investment from Eli Lilly and Company, which underscores its commitment to advancing diabetes care technology.

MicroTech Medical

Series B in 2016
MicroTech Medical, established in January 2011 in Hangzhou Future Technical City, focuses on the research, development, manufacturing, and commercialization of diabetes management devices. The company aims to innovate and produce high-tech and affordable medical devices for diabetes care, including both treatment and monitoring solutions. With a significant portion of its revenue generated in China, MicroTech Medical is dedicated to enhancing diabetes management both domestically and globally. The company has received investment from Eli Lilly and Company, which underscores its commitment to advancing diabetes care technology.

fudaojun.com

Series A in 2016
fudaojun.com is an online educational platform that provides online education tutoring services.

SkyRover

Angel Round in 2016
SkyRover specializes in the research and development, production, sales, and service of high-performance general aviation aircraft.

Gowild

Series A in 2016
Shenzhen Gowild Intelligent Technology Co., Ltd., established in 2013 and headquartered in Shenzhen, China, specializes in the manufacturing of consumer electronics. The company produces a range of innovative products, including smart speakers, artificial intelligence-based housekeeping robots, and holographic AI devices. With a strong emphasis on artificial intelligence and advanced technologies, Gowild aims to blend technology and design, creating fashionable and functional products. The company is committed to exploring the potential of AI to enhance everyday life and believes that the integration of artificial intelligence will play a crucial role in shaping the future.

Yurucheng

Yurucheng provides dental products. The company also conduct research and development, produce, sell, and service medical and dental materials and equipment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.